Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Verstuyf

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 29, 2001
Development of analogues of 1alpha,25-dihydroxyvitamin D3 with biased side chain orientation: methylated des-C,D-homo analoguesS Gabriëls, D Van Haver, M Vandewalle, et al.
Bone|April 12, 2003
Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves boneE Van Etten, D D Branisteanu, L Overbergh, et al.
Transplantation|June 1, 2000
Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressantsE van Etten, D D Branisteanu, A Verstuyf, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃E Vanoirbeek, A Krishnan, G Eelen, et al.
International Journal of Cancer|March 29, 1995
The human immunodeficiency virus(HIV) inhibitor 9-(2-phosphonylmethoxyethyl)adenine (PMEA) is a strong inducer of differentiation of several tumor cell linesJ Balzarini, A Verstuyf, S Hatse, et al.
Clinical and Experimental Immunology|May 3, 2002
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3C Gysemans, E Van Etten, L Overbergh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 2, 2013
A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytesG B Ferreira, F Baeke, A Verstuyf, et al.
Calcified Tissue International|March 22, 2002
The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat modelL Vandenput, J V Swinnen, E Van Herck, et al.
Journal of Medicinal Chemistry|September 10, 1999
Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20X Zhou, G D Zhu, D Van Haver, et al.
Oncogene|April 16, 2013
PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin DE Vanoirbeek, G Eelen, L Verlinden, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 29, 2001
Development of analogues of 1alpha,25-dihydroxyvitamin D3 with biased side chain orientation: methylated des-C,D-homo analoguesS Gabriëls, D Van Haver, M Vandewalle, et al.
Bone|April 12, 2003
Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves boneE Van Etten, D D Branisteanu, L Overbergh, et al.
Transplantation|June 1, 2000
Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressantsE van Etten, D D Branisteanu, A Verstuyf, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃E Vanoirbeek, A Krishnan, G Eelen, et al.
International Journal of Cancer|March 29, 1995
The human immunodeficiency virus(HIV) inhibitor 9-(2-phosphonylmethoxyethyl)adenine (PMEA) is a strong inducer of differentiation of several tumor cell linesJ Balzarini, A Verstuyf, S Hatse, et al.
Clinical and Experimental Immunology|May 3, 2002
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3C Gysemans, E Van Etten, L Overbergh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 2, 2013
A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytesG B Ferreira, F Baeke, A Verstuyf, et al.
Calcified Tissue International|March 22, 2002
The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat modelL Vandenput, J V Swinnen, E Van Herck, et al.
Journal of Medicinal Chemistry|September 10, 1999
Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20X Zhou, G D Zhu, D Van Haver, et al.
Oncogene|April 16, 2013
PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin DE Vanoirbeek, G Eelen, L Verlinden, et al.
Pageof 5